Men's Beliefs About Associations Between HPV, Cancers, and HPV Vaccination

Anus Neoplasms Clinical Trial

Official title:

Men's Beliefs About Associations Between HPV, Cancers, and HPV Vaccination

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00799474
• Other study ID #: Merck-558377
• Status: Completed
• Phase: N/A
• First received: November 26, 2008
• Last updated: January 20, 2010
• Start date: December 2008
• Est. completion date: January 2009

Study information

• Verified date: January 2010
• Source: University of North Carolina, Chapel Hill
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

This research focuses on men who have sex with men (MSM) who are at higher risk of anal cancer. The survey will evaluate their beliefs about anal and oral cancer, their knowledge about role of human papillomavirus (HPV) infection in these cancers, and their knowledge of HPV vaccination and anal Pap smears. Approximately 12% of subjects will be HIV-positive.

Description:

Little research has examined men's understanding of what causes anal and oral cancers and whether HPV vaccination can play a potential protective role. This research focuses on men who have sex with men (MSM) who are at notably elevated risk of anal cancer, and seeks to characterize their beliefs about anal and oral cancer, knowledge about the etiological role of HPV infection in these cancers, as well as their knowledge of HPV vaccination and anal Pap smears. We will also study heterosexual men.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 609
• Est. completion date: January 2009
• Est. primary completion date: January 2009
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 59 Years

Eligibility

Inclusion Criteria:

• male

• aged 18-59

• answered question about sexual orientation

Exclusion Criteria:

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Anus Neoplasms

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
University of North Carolina, Chapel Hill	Merck Sharp & Dohme Corp.

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Willingness to Receive the Human Papillomavirus (HPV) Vaccine		at time of interview	No
Secondary	Awareness of HPV Vaccine		At time of interview	No
Secondary	Knowledge of HPV		At time of interview	No